Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia. These individuals were twice as likely to report that they were COVID-19 vaccine hesitant – they would put off getting vaccinated or never get the jab.

Medical syringe needle

This new study indicates that if all injection anxiety in the population was removed then just over 10% of instances of vaccine hesitancy might disappear too.  

Researchers from the University of Oxford, funded by the National Institute for Health (NIHR) Research Oxford Biomedical Research Centre (BRC) and the Oxford Health BRC, asked a representative group of 15,014 UK adults in the third Oxford Coronavirus Explanations, Attitudes, and Narratives Survey (OCEANS-III) to rate their anxieties about needles and blood, and asked them about their willingness to receive a COVID-19 vaccine. The results concerning injection fears are published today in the journal Psychological Medicine.

Professor Daniel Freeman, study lead, Department of Psychiatry, University of Oxford, said:

 

‘For people with injection phobia the sight, say, of a hypodermic needle will prompt an initial increase in heart rate and blood pressure. This may be swiftly followed by a sudden decline in both. When that happens, some people faint. The COVID-19 vaccination programme means that almost everyone has had – or will soon have – to face the needle. People may certainly think twice about joining a queue for a vaccine if they fear that they might topple to the ground.’

Typically, people who are vaccine hesitant cite concern about the safety of the vaccines and scepticism about the seriousness of COVID-19. What the survey makes clear now, however, is that fear of the needle may also be playing a part.

The survey also showed that COVID-19 vaccine hesitancy is a little higher among younger people, and certain ethnic minority groups but it is not only vaccine scepticism that’s more common in these groups: it is injection fears too. This is not coincidental. Though they’re certainly not the main factor, the study shows that injection fears partially account for higher rates of vaccine hesitancy in these demographic groups.  

Professor Freeman continues: ‘When it comes to controlling COVID-19, every vaccination counts. There is much that can be done to help people overcome their fear of needles. Cognitive behavioural therapy is typically fast and effective -- and can even be successfully given in group sessions. Treatment involves gradual exposure to needles and injections, beginning with simply showing pictures and videos. Fainting can be tackled too. Patients can be taught how to recognise the early signs of a dip in their blood pressure and to combat this drop by applied muscle tension.’

Helen McShane, Professor of Vaccinology at the University of Oxford, highlighted that:

 

‘There are many different reasons for why people are hesitant about receiving a vaccine. A fear of needles is a significant factor in up to 10% of people who are vaccine hesitant. Whilst needle free routes of vaccination, such as via the nose, are being explored, at present the only approved routes of vaccination for COVID-19 vaccines are by injection. Understanding the underlying causes of this helps us address specific interventions that ultimately will increase vaccine uptake.’

Professor Sir Andrew Pollard, Director of the Oxford Vaccine Group at the University of Oxford said:

 

‘The coronavirus as a public health threat remains with us and those who are unvaccinated will continue to be at risk. Strategies to address protection for the unvaccinated are urgently needed, including getting access to vaccines for those without it and addressing fears and concerns of those who decline.’

 

The Oxford Coronavirus Explanations, Attitudes, and Narratives Survey (OCEANS III) was conducted between 19 January and 5 February 2021 with 15,014 UK adults, quota sampled to match the population for age, gender, ethnicity, income, and region.

The study was funded by the NIHR Oxford BRC and the NIHR Oxford Health BRC.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

What is the Role of Science in Mental Health?

A new summary report, What science has shown can help young people with anxiety and depression - Identifying and reviewing the 'active ingredients' of effective interventions, from Wellcome has been published. It includes new research from Oxford University, which investigates the knowns and unknowns of SSRI treatment (antidepressant drugs) in young people with depression and anxiety.

New Research Presented at the ECNP Conference - October 2021

Dr Angharad de Cates and Dr Liliana Capitão were just two of the department's researchers presenting and publishing new research at the European College of Neuropsychopharmacology (ECNP) Conference 2021, in Lisbon.

Researchers Address Mental Health Effects of the Pandemic on Young People

In a new policy briefing, a team of researchers at King’s College London and Oxford University highlight the multiple effects that the COVID-19 pandemic has had on children and young people in the UK through their education and daily life, including challenges around social isolation, academic pressures, adjusting to online learning and coping with reopening of schools.

Turing Fellowships for Over 30 Oxford Academics

Professor John Geddes, WA Handley-elect Chair of Psychiatry, is one of the thirty-three University of Oxford researchers, which have been named Turing Fellows for the 2021/22 academic year.

Simple Intervention Effectively Treats Depression During COVID 19

New research shows that even a very simple intervention, administered by non-specialists with just 15 hours of training, can effectively treat depression during COVID-19.

Over a Third of COVID-19 Patients Diagnosed with at Least One Long-COVID Symptom

A new study from the University of Oxford and the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC) investigated long-COVID in over 270,000 people recovering from COVID-19 infection, using data from the US-based TriNetX electronic health record network.